Investing.com – Belgium stocks were higher after the close on Wednesday, as gains in the Pharma & Bio-technology, Healthcare and Technology sectors led shares higher.
At the close in Brussels, the BEL 20 added 1.86%.
The best performers of the session on the BEL 20 were UCB (BRU:UCB), which rose 3.77% or 2.43 points to trade at 66.82 at the close. Meanwhile, Anheuser-Busch Inbev SA (BRU:ABI) added 2.84% or 3.05 points to end at 110.55 and Delhaize Group (BRU:DELB) was up 2.66% or 1.97 points to 76.03 in late trade.
The worst performers of the session were Proximus NV (BRU:PROX), which rose 0.17% or 0.06 points to trade at 31.73 at the close. GDF Suez (PARIS:GSZ) added 0.42% or 0.07 points to end at 16.71 and Befimmo-Sicafi (BRU:BEFBb) was up 0.53% or 0.290 points to 55.200.
Rising stocks outnumbered declining ones on the Brussels Stock Exchange by 133 to 30 and 9 ended unchanged.
Gold for August delivery was down 0.20% or 2.30 to $1169.50 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in August fell 3.09% or 1.84 to hit $57.63 a barrel, while the August Brent oil contract fell 1.58% or 1.00 to trade at $62.59 a barrel.
EUR/USD was down 0.60% to 1.1076, while EUR/GBP fell 0.08% to 0.7094.
The US Dollar Index was up 0.59% at 96.32.